Global point of care
The i-STAT Creatinine test is used for the quantitative determination of creatinine (crea) in whole blood on the i-STAT handheld. Creatinine measurements are used in the diagnosis and treatment of renal diseases, in monitoring renal dialysis, and as a calculation basis for measuring other urine analytes.
This basic metabolic panel for use in the in vitro quantification of creatinine in whole blood samples allows healthcare professionals to obtain results in approximately two minutes to detect elevated levels of creatinine mainly associated with abnormal renal function occurring whenever there is a significant reduction in glomerular filtration rate or when urine elimination is obstructed.
Imaging agents (such as iodine and barium) used in radiological procedures can pose serious health risks to patients with certain conditions. To minimize risk, creatinine measurement of renal function is recommended prior to administering imaging agents. Because it may take several hours for the clinical lab to process creatinine tests, i-STAT Crea tests can be used to minimize disruptions and improve efficiencies.
In an article published in British Journal of General Practice, i-STAT Crea test values showed excellent correlation (R2 = 0.99) compared with core lab values, with the authors concluding that the i-STAT System could help improve efficiency, providing accurate, up-to-date creatinine/eGFR values in patients presenting for scans requiring contrast media.1
| Chemistries/Electrolytes |
| Creatinine (Crea) |
| Chemistries/Electrolytes |
| Reportable Range | |
| Creatinine (Crea) | 0.2-20.0 mg/dL, 18-1768 μmol/L |
Reference ranges (sometimes referred to as normal ranges) in the default Customization profile can be found behind login on the i-STAT Cartridge and Test Information (CTI) Sheets/Instructions for Use (IFU) page. This page is only accessible to registered i-STAT customers.
1. Oghenekome Gbinigie, et al, Creatinine Point-of-Care Testing for Detection and Monitoring of Chronic Kidney Disease: Primary Care Diagnostic Technology Update, British Journal of General Practice, November 2015.
| i-STAT System | Code |
|---|---|
i-STAT CREA | 03P84-25 |
A leader in rapid point-of-care diagnostics
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement.
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.
